Vaccine Trial Centre : COVID-19 Vaccine Project Timeline

2019
2020
2021
A Phase 1/2 Randomized, Placebo-controlled, Observer-blind Trial to Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand (GPO NDV-HXP-S)
A Phase 1/2 Study to Evaluated the Safety Reactogenicity and Immunogenicity of Ad26.COV2.S Administered as a Heterologous Booster Vaccination with an Inactivated COVID-19 vaccine (Thai Cov Boost)
2023
NRCT9-1 , NRCT9-2